Dmitry Balyasny’s CONMED CNMD Stock Holding History

Dmitry Balyasny’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-106,785	Closed	-$3.78M	–	3065
2026 Q1	$3.78M	Buy	+106,785	New	+$4.34M	﹤0.01%	1488
2025 Q3	–	Sell	-24,623	Closed	-$1.28M	–	2985
2025 Q2	$1.28M	Sell	24,623 -68,901	-74%	-$3.78M	﹤0.01%	1950
2025 Q1	$5.65M	Buy	+93,524	New	+$6.03M	0.01%	1189
2024 Q4	–	Sell	-95,450	Closed	-$6.86M	–	2814
2024 Q3	$6.86M	Sell	95,450 -76,566	-45%	-$5.4M	0.01%	1125
2024 Q2	$11.9M	Sell	172,016 -128,831	-43%	-$9.4M	0.02%	805
2024 Q1	$24.1M	Buy	300,847 +261,126	+657%	+$23.3M	0.04%	546
2023 Q4	$4.35M	Sell	39,721 -41,578	-51%	-$4.3M	0.01%	1165
2023 Q3	$8.2M	Buy	+81,299	New	+$9.34M	0.02%	921
2023 Q2	–	Sell	-37,099	Closed	-$3.85M	–	2340
2023 Q1	$3.85M	Sell	37,099 -21,370	-37%	-$2.07M	0.01%	1183
2022 Q4	$5.18M	Buy	+58,469	New	+$4.85M	0.01%	1007
2022 Q3	–	Sell	-216,495	Closed	-$20.7M	–	2898
2022 Q2	$20.7M	Buy	216,495 +9,359	+5%	+$1.12M	0.07%	412
2022 Q1	$30.8M	Buy	+207,136	New	+$28.9M	0.1%	277
2021 Q4	–	Sell	-110,571	Closed	-$14.5M	–	2287
2021 Q3	$14.5M	Buy	+110,571	New	+$14.5M	0.06%	433
2021 Q2	–	Sell	-123,231	Closed	-$16.1M	–	2014
2021 Q1	$16.1M	Buy	+123,231	New	+$14.8M	0.08%	337
2020 Q4	–	Sell	-138,097	Closed	-$10.9M	–	1373
2020 Q3	$10.9M	Sell	138,097 -65,306	-32%	-$5.33M	0.08%	359
2020 Q2	$14.6M	Buy	+203,403	New	+$14.2M	0.13%	241
2019 Q3	–	Sell	-57,182	Closed	-$4.89M	–	1225
2019 Q2	$4.89M	Buy	57,182 +45,464	+388%	+$3.74M	0.03%	615
2019 Q1	$975K	Buy	11,718 +5,814	+98%	+$422K	0.01%	1030
2018 Q4	$379K	Buy	5,904 +2,036	+53%	+$139K	﹤0.01%	1165
2018 Q3	$306K	Sell	3,868 -7,296	-65%	-$564K	﹤0.01%	1501
2018 Q2	$817K	Sell	11,164 -2,087	-16%	-$142K	﹤0.01%	1187
2018 Q1	$839K	Buy	+13,251	New	+$791K	﹤0.01%	1287
2017 Q3	–	Sell	-128,809	Closed	-$6.56M	–	1904
2017 Q2	$6.56M	Sell	128,809 -164,598	-56%	-$8.14M	0.03%	676
2017 Q1	$13M	Buy	+293,407	New	+$12.6M	0.06%	402
2016 Q4	–	Sell	-195,001	Closed	-$7.81M	–	1360
2016 Q3	$7.81M	Buy	195,001 +190,803	+4,545%	+$8.1M	0.05%	436
2016 Q2	$200K	Buy	+4,198	New	+$178K	﹤0.01%	1037
2014 Q4	–	Sell	-51,553	Closed	-$1.9M	–	675
2014 Q3	$1.9M	Buy	+51,553	New	+$2.05M	0.01%	612
2014 Q2	–	Sell	-69,433	Closed	-$3.02M	–	648
2014 Q1	$3.02M	Buy	69,433 +56,470	+436%	+$2.52M	0.03%	439
2013 Q4	$551K	Buy	+12,963	New	+$493K	0.01%	456

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Dmitry Balyasny's CNMD Position: Q2 2026 in Review

Dmitry Balyasny sold out of CONMED (CNMD) in Q2 2026, closing a stake of 106,785 shares — an estimated $3.78M sold.

Dmitry Balyasny first reported a position in CNMD in Q4 2013 and held it in 29 quarters. The position peaked at $30.8M in Q1 2022. 245 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Dmitry Balyasny reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 106,785 CONMED shares in Q2 2026, an estimated $3.78M.
Dmitry Balyasny first reported a position in CONMED in Q4 2013 and held it in 29 quarters.
Dmitry Balyasny's CONMED position peaked at $30.8M in Q1 2022.
245 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.